Seagen
Utility Patents
Last updated:
List of all Seagen patents 28 in total
| Status | Patent |
|---|---|
Grant | Utility: Anti-TIGIT antibodies Filling date: 6 Sep 2025 Issue date: 2 Aug 2022 |
Grant | Utility: Process for the preparation of tubulysins and intermediates thereof Filling date: 6 Sep 2025 Issue date: 19 Jul 2022 |
Grant | Utility: Weekly dosing regimens for anti-CD30 vc-PAB-MMAE antibody drug-conjugates Filling date: 6 Sep 2025 Issue date: 28 Jun 2022 |
Grant | Utility: Anti-NTB-A antibodies and related compositions and methods Filling date: 6 Sep 2025 Issue date: 7 Jun 2022 |
Grant | Utility: CD19 binding agents and uses thereof Filling date: 6 Sep 2025 Issue date: 17 May 2022 |
Grant | Utility: Methods and compositions for making antibodies and antibody derivatives with reduced core fucosylation Filling date: 6 Sep 2025 Issue date: 3 May 2022 |
Grant | Utility: Humanized antibodies to LIV-1 and use of same to treat cancer Filling date: 6 Sep 2025 Issue date: 8 Mar 2022 |
Grant | Utility: Glycan-interacting compounds and methods of use Filling date: 6 Sep 2025 Issue date: 22 Feb 2022 |
Grant | Utility: Bivalent antibodies masked by coiled coils Filling date: 6 Sep 2025 Issue date: 25 Jan 2022 |
Grant | Utility: Dosage and administration of non-fucosylated anti-CD40 antibodies Filling date: 6 Sep 2025 Issue date: 4 Jan 2022 |
Grant | Utility: Treatment of HER2 positive cancers Filling date: 6 Sep 2025 Issue date: 28 Dec 2021 |
Grant | Utility: Dosage and administration of non-fucosylated anti-CD40 antibodies Filling date: 6 Sep 2025 Issue date: 21 Dec 2021 |
Grant | Utility: Combinations of PBD-based antibody drug conjugates with FLT3 inhibitors Filling date: 6 Sep 2025 Issue date: 7 Dec 2021 |
Grant | Utility: CD47 antibodies and uses thereof for treating cancer Filling date: 6 Sep 2025 Issue date: 23 Nov 2021 |
Grant | Utility: Intact mass determination of protein conjugated agent compounds Filling date: 6 Sep 2025 Issue date: 9 Nov 2021 |
Grant | Utility: Methylene carbamate linkers for use with targeted-drug conjugates Filling date: 6 Sep 2025 Issue date: 14 Sep 2021 |
Grant | Utility: Combination of CD33 antibody drug conjugates with chemotherapeutic agents Filling date: 6 Sep 2025 Issue date: 7 Sep 2021 |
Grant | Utility: Pegylated drug-linkers for improved ligand-drug conjugate pharmacokinetics Filling date: 6 Sep 2025 Issue date: 31 Aug 2021 |
Grant | Utility: Weekly dosing regimens for anti-CD30 vc-PAB-MMAE antibody drug-conjugates Filling date: 6 Sep 2025 Issue date: 3 Aug 2021 |
Grant | Utility: BCMA antibodies and use of same to treat cancer and immunological disorders Filling date: 6 Sep 2025 Issue date: 3 Aug 2021 |
Grant | Utility: Methods of inhibition of protein fucosylation in vivo using fucose analogs Filling date: 6 Sep 2025 Issue date: 15 Jun 2021 |
Grant | Utility: Combinations of PBD-based antibody drug conjugates with Bcl-2 inhibitors Filling date: 6 Sep 2025 Issue date: 8 Jun 2021 |
Grant | Utility: Glycan-interacting compounds and methods of use Filling date: 6 Sep 2025 Issue date: 8 Jun 2021 |
Grant | Utility: Weekly dosing regimens for anti-CD30 vc-PAB-MMAE antibody drug-conjugates Filling date: 6 Sep 2025 Issue date: 9 Mar 2021 |
Grant | Utility: Hydrophilic antibody-drug conjugates Filling date: 6 Sep 2025 Issue date: 2 Mar 2021 |
Grant | Utility: Weekly dosing regimens for anti-CD30 vc-PAB-MMAE antibody drug-conjugates Filling date: 6 Sep 2025 Issue date: 9 Feb 2021 |
Grant | Utility: Antibody drug conjugates (ADC) that bind to 191P4D12 proteins Filling date: 6 Sep 2025 Issue date: 19 Jan 2021 |
Grant | Utility: Antibody drug conjugates (ADC) that bind to 191P4D12 proteins Filling date: 6 Sep 2025 Issue date: 12 Jan 2021 |
Showing 1 to 28 of 28 patents.